PHTF2_HUMAN - dbPTM
PHTF2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PHTF2_HUMAN
UniProt AC Q8N3S3
Protein Name Putative homeodomain transcription factor 2
Gene Name PHTF2
Organism Homo sapiens (Human).
Sequence Length 785
Subcellular Localization Nucleus .
Protein Description May play a role in transcription regulation..
Protein Sequence MASKVTDAIVWYQKKEFLSVATTAPGPQQVLPGYCQCSLKDQGLFIQCLIGAYDQQIWEKSVEQREIKFIKLGLRNKPKKTAHVKPDLIDVDLVRGSAFAKAKPESPWTSLTRKGIVRVVFFPFFFRWWLQVTSKVIFFWLLVLYLLQVAAIVLFCSTSSPHSIPLTEVIGPIWLMLLLGTVHCQIVSTRTPKPPLSTGGKRRRKLRKAAHLEVHREGDGSSTTDNTQEGAVQNHGTSTSHSVGTVFRDLWHAAFFLSGSKKAKNSIDKSTETDNGYVSLDGKKTVKSGEDGIQNHEPQCETIRPEETAWNTGTLRNGPSKDTQRTITNVSDEVSSEEGPETGYSLRRHVDRTSEGVLRNRKSHHYKKHYPNEDAPKSGTSCSSRCSSSRQDSESARPESETEDVLWEDLLHCAECHSSCTSETDVENHQINPCVKKEYRDDPFHQSHLPWLHSSHPGLEKISAIVWEGNDCKKADMSVLEISGMIMNRVNSHIPGIGYQIFGNAVSLILGLTPFVFRLSQATDLEQLTAHSASELYVIAFGSNEDVIVLSMVIISFVVRVSLVWIFFFLLCVAERTYKQRLLFAKLFGHLTSARRARKSEVPHFRLKKVQNIKMWLSLRSYLKRRGPQRSVDVIVSSAFLLTISVVFICCAQLLHVHEIFLDCHYNWELVIWCISLTLFLLRFVTLGSETSKKYSNTSILLTEQINLYLKMEKKPNKKEELTLVNNVLKLATKLLKELDSPFRLYGLTMNPLLYNITQVVILSAVSGVISDLLGFNLKLWKIKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure		 ASA (%) Reference Orthologous
Protein Cluster
26 (in isoform 4)Ubiquitination-30.1321906983
26UbiquitinationSVATTAPGPQQVLPG
EEECCCCCCCCCCCC		30.13-
26UbiquitinationSVATTAPGPQQVLPG
EEECCCCCCCCCCCC		30.1329967540
26 (in isoform 2)Ubiquitination-30.1321906983
26 (in isoform 3)Ubiquitination-30.1321906983
47UbiquitinationKDQGLFIQCLIGAYD
CCCCHHHHHHHHHHH		14.5029967540
60UbiquitinationYDQQIWEKSVEQREI
HHHHHHHHHHHHHHH		44.822190698
77AcetylationIKLGLRNKPKKTAHV
EEECCCCCCCCCCCC		52.3518586777
103UbiquitinationGSAFAKAKPESPWTS
CCHHHCCCCCCCCCC		48.92-
201AcetylationPPLSTGGKRRRKLRK
CCCCCCCHHHHHHHH		44.0419809995
221PhosphorylationVHREGDGSSTTDNTQ
EECCCCCCCCCCCCC		29.2917081983
222PhosphorylationHREGDGSSTTDNTQE
ECCCCCCCCCCCCCC		40.6417081983
223PhosphorylationREGDGSSTTDNTQEG
CCCCCCCCCCCCCCC		39.6117081983
224PhosphorylationEGDGSSTTDNTQEGA
CCCCCCCCCCCCCCC		29.2417081983
227PhosphorylationGSSTTDNTQEGAVQN
CCCCCCCCCCCCCCC		30.7017081983
231UbiquitinationTDNTQEGAVQNHGTS
CCCCCCCCCCCCCCC		10.0429967540
235UbiquitinationQEGAVQNHGTSTSHS
CCCCCCCCCCCCCCC		24.6629967540
237PhosphorylationGAVQNHGTSTSHSVG
CCCCCCCCCCCCCHH		22.6817081983
238PhosphorylationAVQNHGTSTSHSVGT
CCCCCCCCCCCCHHH		32.2917081983
239PhosphorylationVQNHGTSTSHSVGTV
CCCCCCCCCCCHHHH		30.2317081983
240PhosphorylationQNHGTSTSHSVGTVF
CCCCCCCCCCHHHHH		17.3317081983
245PhosphorylationSTSHSVGTVFRDLWH
CCCCCHHHHHHHHHH		17.8324719451
260PhosphorylationAAFFLSGSKKAKNSI
HHHHHHCCHHHHHCC		27.8324260401
277PhosphorylationSTETDNGYVSLDGKK
CCCCCCCEEEECCCE		7.9723312004
279PhosphorylationETDNGYVSLDGKKTV
CCCCCEEEECCCEEE		16.5625849741
314PhosphorylationETAWNTGTLRNGPSK
CCCCCCCCCCCCCCC		22.10-
326PhosphorylationPSKDTQRTITNVSDE
CCCCCCCEEEECCCC		23.4923663014
328PhosphorylationKDTQRTITNVSDEVS
CCCCCEEEECCCCCC		29.0223663014
329N-linked_GlycosylationDTQRTITNVSDEVSS
CCCCEEEECCCCCCC		27.69-
331PhosphorylationQRTITNVSDEVSSEE
CCEEEECCCCCCCCC		30.0822115753
335PhosphorylationTNVSDEVSSEEGPET
EECCCCCCCCCCCCC		29.9522115753
336PhosphorylationNVSDEVSSEEGPETG
ECCCCCCCCCCCCCC		44.8622115753
342PhosphorylationSSEEGPETGYSLRRH
CCCCCCCCCCCHHHH		44.5530108239
344PhosphorylationEEGPETGYSLRRHVD
CCCCCCCCCHHHHCC		16.3823090842
345PhosphorylationEGPETGYSLRRHVDR
CCCCCCCCHHHHCCC		19.4224719451
378PhosphorylationPNEDAPKSGTSCSSR
CCCCCCCCCCCHHHH		46.36-
478PhosphorylationDCKKADMSVLEISGM
CCCCCCCCHHHHHHH		24.8924719451
483PhosphorylationDMSVLEISGMIMNRV
CCCHHHHHHHHHHHH		16.9724719451
689PhosphorylationLRFVTLGSETSKKYS
HHHHHHCCCCCCCCC		40.5923090842
691PhosphorylationFVTLGSETSKKYSNT
HHHHCCCCCCCCCCC		47.7623090842
692PhosphorylationVTLGSETSKKYSNTS
HHHCCCCCCCCCCCE		24.0923090842
695PhosphorylationGSETSKKYSNTSILL
CCCCCCCCCCCEEEE		15.7621712546
696PhosphorylationSETSKKYSNTSILLT
CCCCCCCCCCEEEEH		42.3821712546
697N-linked_GlycosylationETSKKYSNTSILLTE
CCCCCCCCCEEEEHH		34.45-
698PhosphorylationTSKKYSNTSILLTEQ
CCCCCCCCEEEEHHH		15.94-
699PhosphorylationSKKYSNTSILLTEQI
CCCCCCCEEEEHHHH		18.5824248375
703PhosphorylationSNTSILLTEQINLYL
CCCEEEEHHHHHHHH		23.5421712546
709PhosphorylationLTEQINLYLKMEKKP
EHHHHHHHHHCCCCC		10.3724248375
7372-HydroxyisobutyrylationKLATKLLKELDSPFR
HHHHHHHHHCCCCHH		67.67-
756N-linked_GlycosylationTMNPLLYNITQVVIL
CCCHHHHHHHHHHHH		30.70-
Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PHTF2_HUMAN !!
Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PHTF2_HUMAN !!
Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10) 		Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PHTF2_HUMAN !!
Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of PHTF2_HUMAN !!
Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PHTF2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP
© 2024 Institute of Bioinformatics and Systems Biology, NYCU | Designed by : BiOmics Laboratory